Document is current
Any future updates will be listed below
-
Authors
Thurimella, Kumar
Mohamed, Ahmed M. T.
Li, Chenhao
Vatanen, Tommi
Graham, Daniel B.
Owens, Róisín M.
La Rosa, Sabina Leanti
Plichta, Damian R.
Bacallado, Sergio
Xavier, Ramnik J.
-
Funding
Funding for this research was provided by:
Gates Cambridge Trust
Rotary Foundation
National Institutes of Health
- License Information
-
More Information
Article History
Received: 9 September 2025
Accepted: 26 September 2025
First Online: 26 November 2025
Declarations
:
: Not applicable.
: Not applicable.
: R.J.X. is a co-founder of Jnana Therapeutics and Convergence Bio, scientific advisory board member at Nestlé, Magnet BioMedicine, and Arena BioWorks, and board director at MoonLake Immunotherapeutics. D.R.P. is an employee of Novozymes A/S, Denmark. These organizations had no roles in this study.
